The European Association of Addiction Therapy - Inaugural Conference.
Mucke
Hermann A M
HA
HM Pharma Consultancy, Enenkelstrasse 28/32, Wien, Austria. office@hmpharmacon.com
D000108:Acetylcarnitine / Q000737:chemistry / Q000627:therapeutic use; D000818:Animals; D002800:Cholinesterase Inhibitors / Q000737:chemistry / Q000627:therapeutic use; D003226:Congresses as Topic; D003687:Dehydroepiandrosterone / Q000627:therapeutic use; D006801:Humans; D009570:Nitriles / Q000737:chemistry / Q000627:therapeutic use; D010879:Piperazines / Q000737:chemistry / Q000627:therapeutic use; D011799:Quinazolines / Q000737:chemistry / Q000627:therapeutic use; D051381:Rats; D012958:Societies, Scientific / Q000458:organization & administration*; D019966:Substance-Related Disorders / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D044005:Tetrahydroisoquinolines / Q000737:chemistry / Q000627:therapeutic use
D002800:Cholinesterase Inhibitors; D009570:Nitriles; D010879:Piperazines; D011799:Quinazolines; C409982:SB 277011; D044005:Tetrahydroisoquinolines; C499396:desoxypeganine 1; C120565:BP 897; D003687:Dehydroepiandrosterone; D000108:Acetylcarnitine